Merck & Co Inc
NYSE: MRK
$100.47
Real Time Data Delayed 15 Min.
MRK Articles
The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly downward.
Published:
Last Updated:
Chevron, DuPont, Merck, and Cisco weighed on the DJIA Tuesday.
Published:
Last Updated:
Apple, DuPont, Merck, and Verizon lead DJIA higher on Friday.
Published:
Last Updated:
Chevron, Merck, Exxon, and McDonald's kept the DJIA above water on Wednesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
Published:
Last Updated:
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
Published:
Last Updated:
DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.
Published:
Last Updated:
Intel, GE, Merck, and Chevron weighed on the DJIA Monday.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.
Published:
Last Updated:
Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type 2 diabetes treatment.
Published:
Last Updated:
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
Published:
Last Updated: